摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Tert-butyl 4-[2-(propan-2-ylsulfonylamino)phenyl]piperazine-1-carboxylate | 444582-43-8

中文名称
——
中文别名
——
英文名称
Tert-butyl 4-[2-(propan-2-ylsulfonylamino)phenyl]piperazine-1-carboxylate
英文别名
——
Tert-butyl 4-[2-(propan-2-ylsulfonylamino)phenyl]piperazine-1-carboxylate化学式
CAS
444582-43-8
化学式
C18H29N3O4S
mdl
——
分子量
383.512
InChiKey
BFQSCEDTWHYYIW-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.5
  • 重原子数:
    26
  • 可旋转键数:
    6
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.61
  • 拓扑面积:
    87.3
  • 氢给体数:
    1
  • 氢受体数:
    6

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Aryl piperazine melanocortin MC4 receptor agonists
    摘要:
    Incorporation of substituted phenyl piperazine privileged structures into a known MC4 specific dipeptoid consensus sequence resulted in a series of potent (EC50 = 24 nM) and selective MC4-R agonists. We report the SAR of this series of compounds using in vitro cAMP functional assays in cells transfected with the MC4 or other melancortin receptors. (C) 2003 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/s0960-894x(03)00796-0
  • 作为产物:
    参考文献:
    名称:
    Aryl piperazine melanocortin MC4 receptor agonists
    摘要:
    Incorporation of substituted phenyl piperazine privileged structures into a known MC4 specific dipeptoid consensus sequence resulted in a series of potent (EC50 = 24 nM) and selective MC4-R agonists. We report the SAR of this series of compounds using in vitro cAMP functional assays in cells transfected with the MC4 or other melancortin receptors. (C) 2003 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/s0960-894x(03)00796-0
点击查看最新优质反应信息

文献信息

  • Melanocortin receptor agonists
    申请人:——
    公开号:US20040092507A1
    公开(公告)日:2004-05-13
    The present invention relates to melanocortin receptor agonists of formula (I), which is useful in the treatment of obesity, diabetes and male and/or female sexual dysfunction. 1
    本发明涉及公式(I)的黑色素皮质素受体激动剂,其在肥胖症、糖尿病和男性和/或女性性功能障碍的治疗中有用。
  • PIPERAZINE DERIVATIVES AS MELANOCORTIN RECEPTOR AGONISTS
    申请人:ELI LILLY AND COMPANY
    公开号:EP1368340A1
    公开(公告)日:2003-12-10
  • US7291619B2
    申请人:——
    公开号:US7291619B2
    公开(公告)日:2007-11-06
  • [EN] MELANOCORTIN RECEPTOR AGONISTS<br/>[FR] DERIVES DE PIPERAZINE AGONISTES DU RECEPTEUR DE LA MELANOCORTINE
    申请人:LILLY CO ELI
    公开号:WO2002059108A1
    公开(公告)日:2002-08-01
    The present invention relates to melanocortin receptor agonists of formula (I), which is useful in the treatment of obesity, diabetes and male and/or female sexual dysfunction.
  • Aryl piperazine melanocortin MC4 receptor agonists
    作者:Brian Dyck、Jessica Parker、Teresa Phillips、Lee Carter、Brian Murphy、Robin Summers、Julia Hermann、Tracy Baker、Mary Cismowski、John Saunders、Val Goodfellow
    DOI:10.1016/s0960-894x(03)00796-0
    日期:2003.11
    Incorporation of substituted phenyl piperazine privileged structures into a known MC4 specific dipeptoid consensus sequence resulted in a series of potent (EC50 = 24 nM) and selective MC4-R agonists. We report the SAR of this series of compounds using in vitro cAMP functional assays in cells transfected with the MC4 or other melancortin receptors. (C) 2003 Elsevier Ltd. All rights reserved.
查看更多